Browse > Article

A Result and Prognostic Factors of Hypofractionation Radiation Therapy in Early Glottic Cancer  

Lee Mi-Jo (Department of Radiation Oncology, College of Medicine, Inha University)
Kim Hun-Jung (Department of Radiation Oncology, College of Medicine, Inha University)
Kim Woo-Chul (Department of Radiation Oncology, College of Medicine, Inha University)
Loh Jun-Gou (Department of Radiation Oncology, College of Medicine, Inha University)
Publication Information
Korean Journal of Head & Neck Oncology / v.21, no.2, 2005 , pp. 132-138 More about this Journal
Abstract
Purpose: The purpose of this study was to establish general guidelines for the treatment of patients with early glottic cancer(T1-2N0M0), by assessing the role of primary radiation therapy and by analyzing the tumor-related and treatment-related factors that influence treatment results. We also studied the results of hypofractionated radiation therapy for early glottic cancer. Material and Methods: This retrospective study comprised 48 patients who suffered from early glottic cancer and were treated by primary radiotherapy at Inha University Hospital, between May 1997 and October 2004. T-stage distribution showed 38 patients as T1 and 10 patients as stage T2. Thirty-eight patients underwent hypofractionated radiotherapy using a 6 MY photon beam, a total tumor dose of 63Gy, in 5 weekly fractions of 2.25Gy, with an overall radiation treatment time of 38 days. Ten patients in the T2 stage tolerated a total dose of 63-72 Gy(median 68.4Gy) in 5 weekly fractions of 1.8-2.0Gy, with an overall radiation treatment time of 40-87 days(median 51 days). All patients were followed up for at least 3 years. Univariate and multivariate analyses were performed to identify the prognostic factors affecting the treatment results. Result: The 5-year survival rate was 92% for all patients, 94% for T1 patients and 91% for T2 patients. The local control rate was 93.5% for all patients, 95% for T1 and 92.2% for T2 patients. Three patients suffered a relapse following radiotherapy, and underwent subsequent salvage surgery. We included T-stage, tumor location, total radiation dose, field size and overall radiation treatment time as potential prognostic factors. Only T-stage was found to be statistically significant in the univariate analysis, but in the multivariate analysis, it was not found to be significant. Conclusion: High curative and voice preservation rates were obtained with hypofractionated radiotherapy. Further study with a larger number of patients is needed to determine the prognostic factors affecting treatment results.
Keywords
Early glottic cancer; Hypofractionated radiation therapy; Prognostic factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Korea cancer statistics, 2002, http://www.ncc.re.kr
2 Mendenhall WM, Amdur RJ, Morris CG, et al: Tl-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001 Oct 15;19 (20):4029-4036   DOI
3 Rudoltz MS, Benammar A, Mohiuddin M: Prognostic factors for local control and survival in Tl squamous cell carcinoma of the glottis. Int J Radiation Oncology Biology Physics. 1993 Aug 1;26 (5):767-772   DOI   ScienceOn
4 Wang CC: Factors influencing the success of radiation therapy for T2 and T3 glottic carcinomas. Importance of cord mobility and sex. American Journal Clinical Oncology. 1986 Dec;9 (6): 517-520   DOI   ScienceOn
5 Hirota S, Soefima T, Obayashi K, et al: Radiotherapy of T1 and T2 glottic cancer. Analysis of anterior commissure involvement. Radiat Med. 1996;14:297-302
6 De Gier HH, Knegt PP, de Boer MF, et al: CO2-laser treatment of recurrent glottic carcinoma. Head and Neck. 2001 ;23:177-180   DOI   ScienceOn
7 Sakata K, Aoki Y, Karasawa K, et al: Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiation Oncology Biology and Physics. 1994 Dec 1;30 (5):1059-1064   DOI   ScienceOn
8 Zohar Y, Rahima M, Shvili Y, et al: The controversial treatment of anterior commissure carcinoma of the larynx. Laryngoscope. 1992;102:69-72
9 Hinerman RW, Mendenhall WM, Amdur RJ, et al: Early laryngeal cancer. Curr Treat Options Oncol. 2002;3:3-9   DOI   ScienceOn
10 Warde P, O'Sullivan B, Bristow RG, et al: T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiation Oncology Biology Physics. 1998 May 1;41 (2):347-353   DOI   ScienceOn
11 Luscher MS, Pedersen U, Johansen LV: Treatment outcome after lase excision of early glottic squamous cell carcinoma- a literature survey. Acta Oncol. 2001;40:796-800   DOI   ScienceOn
12 De Vita VT: Cancer principles and practice of oncology 7th ed. Philadelphia, New york: Lippincott Co, 2005:696-670
13 Schwaibold F, Scariato A, Nunno M, et al; The effect offraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys. 1988 Mar;14 (3):451-454   DOI   ScienceOn
14 Benninger MS, Gillen J, Thieme P, et al: Factors associated with recurrence and voice quality following radiation therapy for T1 and T2 glottic carcinoma. Laryngoscope. 1994;104:294-298
15 American Joint Committee for Cancer: 6th ed. Philadelphia, New York: Lippincott Co, 2002:48-49
16 Fein DA, Mendenhall WM, Parsons JT, Millon RR: T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: Amoltivariate analysis of variables potentially influencing local control. Int J Radiation Oncology Biology Physics. 1993;25:605-611   DOI   ScienceOn
17 Teshima T, Chatani M, Inoue T: Radiation therapy for early glottic cancer (TINOMO): Prospective randomized study concerning radiation field. Int J Radiation Oncology Biology Physics. 1990;18:119-123   DOI   ScienceOn
18 Haugen H, Johansson KA, Mercke C: Hyperfractionated accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys. 2002;52:109-119   DOI   ScienceOn
19 Bron LP, Soldati D, Zouhair A, et al: Treatment of early stage squamous cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck. 2001;23:823-829   DOI   ScienceOn
20 Hall EJ: Time dose and fractionation in radiotherapy. A comparison of two evaluation systems in clinical use. British J Radiology. 1969 Jun:42 (498):427-431   DOI   ScienceOn
21 Yu E, Shenouda G, Beaudet MP, Black MJ: Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37 (3):587-591   DOI   ScienceOn
22 Mendenhall WM, Parsons JT, Stringer SP, et al: Squamous Cell Carcinoma of the Head and Neck Treated With Irradiation: Managementofthe Neck. SeminRadiat Oncol. 1992 Jul;2 (3):163-170   DOI   ScienceOn
23 Garden AS, Morrison WH, Ang KK, Peters LJ: Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: A comparison of two fractionation schedules. Int J Radiat Oncol Bioi Phys. 1995;31 :493-502   DOI   ScienceOn
24 Shvero J, Hadar T, Segal K, et al: T1 glottic carcinoma involving the anterior commissure. Eur J Surg Oncol. 1994;20:557-560
25 Dinshaw KA, Sharma V, Agarwal JP, et al: Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control complications. Int J Radiat Oncol Biol Phys. 2000 Oct 1:48 (3):723-735   DOI   ScienceOn
26 Burke LS, Greven KM, McGuirt WT, et al: Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys. 1997;38: 1001-1006   DOI   ScienceOn
27 Lusinchi A, Dube P, Wibault P, et al: Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiotherapy Oncology. 1989 Aug;15 (4):313-319   DOI   ScienceOn
28 Spector JG, Sessions DG, Chao Ks, et al: Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and consevation surgery. Head and Neck. 1999;21:116-123   DOI   ScienceOn
29 Wang CC, Efird JT: Dose prolonged treatment course adverse affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys. 1994;29:657-660   DOI   ScienceOn
30 Le QT, Takarniya R, Shu HK, et al: Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases. Arch Otolaryngol Head Neck Surg. 2000 Nov;126 (11):1305-1312   DOI